Description Exocrine pancreatic insufficiency (EPI) is a disorder caused by the failure of the
pancreas to deliver a minimum/threshold level of specific pancreatic digestive enzymes to …

Simple Summary Pancreatic ductal carcinomas (PDACs) are difficult to diagnose at an early
stage and carry a poor overall prognosis for patients. Many patients with PDACs have …

Abstract Background and Aims Medium-chain triglyceride (MCT) supplementation is
recommended in cholestatic liver disease, despite unclear evidence and no consensus on …

Cystic fibrosis (CF) is a monogenic disease with different types of mutations that mainly
affect the respiratory-digestive system. Calcium (Ca), phosphorus (P), and vitamin D (Vit-D) …

Evaluation and management of exocrine pancreatic insufficien... : Current Opinion in
Gastroenterology Evaluation and management of exocrine pancreatic insufficiency: pearls and …

Exocrine pancreatic insufficiency (EPI) is highly prevalent among individuals with cystic
fibrosis (CF). Individuals diagnosed with EPI are often labeled as having “pancreas …

Objective Intestinal inflammation with contradictory data on faecal calprotectin (fCP) levels is
documented in patients with cystic fibrosis (CF). The aim of this study was to longitudinally …

Pediatric patients with exocrine pancreatic insufficiency (EPI) have symptoms that include
abdominal pain, weight loss or poor weight gain, malnutrition, and steatorrhea. This …

Fat malabsorption is central to the pathophysiology of short bowel syndrome (SBS). It occurs
in patients with insufficient intestinal surface area and/or function to maintain metabolic and …

Exocrine pancreatic insufficiency (EPI) is common in pancreatic ductal adenocarcinoma
(PDAC) and may lead to significant nutrition compromise. In the setting of cancer cachexia …